A blood filter is a screen-type filter composed of woven mesh made from polyester or nylon, and it is placed between the product bag and the patient for performing filtration. These filters are intended to protect patients from macro-aggregates and non-blood component particulate matter that could be hazardous if enter the bloodstream. They remove macro-aggregates such as micro-aggregate sites and fibrin aggregates during a blood transfusion. Filtration involves capturing particles and macro-aggregates made from leucocytes, fibrin, and platelets, formed during blood storage. Factors such as an increase in the burden of chronic diseases, a surge in cases of trauma and accidents, and a rising number of blood transfusion procedures drive the blood filter market growth. However, product recalls hamper the growth of the market.
You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities
Blood Filter Market: Strategic Insights
Improving the availability of safe and adequate blood for transfusion procedures should be an integral part of every country’s national healthcare policy and infrastructure. The need for blood transfusion may arise anytime in urban and rural areas. In the past, the unavailability of blood has led to the deaths of many patients suffering from ill-health. An adequate and reliable supply of safe blood can be assured by having stable facilities for regular, voluntary, and unpaid blood donors. They are also the safest group of donors as the prevalence of blood-borne infections is the lowest among these donors.
The most common surgeries that require blood transfusion include cardiovascular procedures, C-section procedures, and injuries. As per estimates by the National Heart, Lung, and Blood Institute, and the National Institutes of Health (NIH), in the US, over 5 million people require blood transfusions every year. Moreover, due to natural calamities and widespread causalities, the demand for blood transfusion is increasing across the world. A surge in the incidence of blood disorders such as anemia, erythrocytosis, leukocytosis, leukopenia, and thrombocytosis is also boosting the blood filter market growth. As per the WHO, most of the children with thalassemia are born in low-income countries, where access to blood transfusion is either difficult or is available to a small percentage of the population.
Blood filters used in transfusion procedures are woven mesh made from polyester or nylon; these are screen-type filters placed between the product bag and the patient. These filters are designed to protect the patients from potentially harmful macro-aggregates such as platelets, leucocytes, and fibrin proteins, and non-blood component particulate matter. In the majority of developed countries, the blood transfusion filters are provided by governments or community-based programs. Thus, the availability of suitable facilities for blood donation and voluntary donor drives the number of blood transfusion procedures, which boosts the blood filler market growth.
Based on product, the blood filter market is further segmented into 40 microns and 70 microns, 100 microns and 170 microns, and others. The 100 microns and 170 microns segment would hold the largest market share in 2021 and is expected to register a higher CAGR during the forecast period.
Based on material, the blood filter market is segmented into polycarbonate, polyester, ABS, and others. The polyester segment would hold the largest market share of 35.47% in 2021, and it is expected to retain its dominance during the forecast period.
Based on application, the blood filter market is segmented into blood processing and blood transfusion. The blood transfusion segment would hold the largest market share of 73.83% in 2021, and it is expected to retain its dominance during the forecast period.
Based on end-user, the blood filter market is segmented into blood banks, hospitals, and others. The blood banks segment would hold the largest market share of 47.38% in 2021 and is expected to retain its dominance during the forecast period.
Various companies operating in the blood filter market are adopting strategies such as product launches, mergers and acquisitions, collaborations, product innovations, and product portfolio expansions to expand their footprint worldwide, maintain the brand name, and meet the growing demand from end-users.
The regional trends and factors influencing the Blood Filter Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Blood Filter Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 405.226 Million |
| Market Size by 2028 | US$ 535.634 Million |
| Global CAGR (2021 - 2028) | 4.1% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Product
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
The Blood Filter Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Blood Filter Market are:
Disclaimer: The companies listed above are not ranked in any particular order.
Global blood filter market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. In North America, The US holds the largest size of the market in this region. Nearly 16 million blood components are transfused each year in the U.S. According to the American Cancer Society, more than 1.8 million people are expected to be diagnosed with cancer in 2020. Many of them will need blood, sometimes daily, during their chemotherapy treatment. Blood products are transfused through intravenous tubing with filters. The filters, which typically have pore diameters of 170 to 260 microns, are used to prevent particulate debris from being administered as well. The trapped material promotes bacterial growth, and the American Association of Blood Banks (AABB) recommends not using a filter for more than 4 hours. The government is also experiencing increasing chronic conditions such as acute kidney injury (AKI), multiple organ dysfunction syndromes, or sepsis. Thus, it is expected that rising incidences of chronic diseases are likely to influence the market's growth. Moreover, the rise in transplant procedures across the United States is expected to increase the blood transfer procedures that require collection units such as tubes, bags, and others. According to the Red Cross Blood Center, 4.5 million Americans require blood transfusion annually.
The blood filter market majorly consists of players such Asahi Kasei Corporation, Fresenius Kabi AG, Macopharma, Haemonetics Corporation, Infomed SA, KANEKA CORPORATION, Kawasumi laboratories. Inc., Sefar AG, Shandong Zhongbaokang Medical Implements Co., Ltd, Nanjing Shuangwei Biotechnology Co., Ltd. among others.
The blood transfusion segment dominated the global blood filter market and accounted for the largest revenue share of 73.83% in 2021
The blood banks segment dominated the global colon blood filter market and accounted for the largest revenue share of 47.38% in 2021.
A blood filter is a screen-type filter composed of woven mesh made from polyester or nylon, and it is placed between the product bag and the patient for performing filtration. These filters are intended to protect patients from macro-aggregates and non-blood component particulate matter that could be hazardous if enter the bloodstream. They remove macro-aggregates such as micro-aggregate sites and fibrin aggregates during a blood transfusion. Filtration involves capturing particles and macro-aggregates made from leucocytes, fibrin, and platelets, formed during blood storage.
Key factors that are driving the growth of this market are an increase in the burden of chronic diseases, a surge in cases of trauma and accidents, and a rising number of blood transfusion procedures are expected to boost the market growth for the blood filter over the years.
The 100micron and 170-micron segment dominated the global blood filter market and held the largest revenue share of 56.80% in 2021.
The polyester segment dominated the global blood filter market and held the largest revenue share of 35.47% in 2021.